Skip to content

Investigator

Hans Gregersen

CALIFORNIA MEDICAL INNOVATIONS INSTITUTE · funded by NIDDK

Companies
2

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$2.0M

Summed across those awards.

First award
Jun 15, 2021

Latest Mar 1, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation.

    $370k

    Mar 1, 2023NIDDKCALIFORNIA MEDICAL INNOVATIONS INSTITUTENIH RePORTER · 11060050 (opens the source filing in a new tab)

  2. R01

    Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics

    $535k

    Aug 1, 2022NIDDKCALIFORNIA MEDICAL INNOVATIONS INSTITUTENIH RePORTER · 11140302 (opens the source filing in a new tab)

  3. R01

    Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics

    $523k

    Aug 1, 2022NIDDKCALIFORNIA MEDICAL INNOVATIONS INSTITUTENIH RePORTER · 11374528 (opens the source filing in a new tab)

  4. R01

    Defecation mechanisms and subtyping of constipation patients with Fecobionics

    $544k

    Jun 15, 2021NIDDKCALIFORNIA MEDICAL INNOVATIONS INSTITUTENIH RePORTER · 11164491 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources